Characterizing Risk in Climate Change Assessments

Characterizing Risk in Climate Change Assessments
Author :
Publisher : National Academies Press
Total Pages : 101
Release :
ISBN-10 : 9780309445542
ISBN-13 : 030944554X
Rating : 4/5 (54X Downloads)

Book Synopsis Characterizing Risk in Climate Change Assessments by : National Academies of Sciences, Engineering, and Medicine

Download or read book Characterizing Risk in Climate Change Assessments written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2016-10-25 with total page 101 pages. Available in PDF, EPUB and Kindle. Book excerpt: The U.S. Global Change Research Program (USGCRP) was established in 1990 to "assist the Nation and the world to understand, assess, predict, and respond to human-induced and natural processes of global change."1 A key responsibility for the program is to conduct National Climate Assessments (NCAs) every 4 years.2 These assessments are intended to inform the nation about "observed changes in climate, the current status of the climate, and anticipated trends for the future." The USGCRP hopes that government entities from federal agencies to small municipalities, citizens, communities, and businesses will rely on these assessments of climate- related risks for planning and decision-making. The third NCA (NCA3) was published in 2014 and work on the fourth is beginning. The USGCRP asked the Board on Environmental Change and Society of the National Academies of Sciences, Engineering, and Medicine to conduct a workshop to explore ways to frame the NCA4 and subsequent NCA reports in terms of risks to society. The workshop was intended to collect experienced views on how to characterize and communicate information about climate-related hazards, risks, and opportunities that will support decision makers in their efforts to reduce greenhouse gas emissions, reduce vulnerability to likely changes in climate, and increase resilience to those changes. Characterizing Risk in Climate Change Assessments summarizes the presentations and discussions from the workshop.


Characterizing Risk in Climate Change Assessments Related Books

Characterizing Risk in Climate Change Assessments
Language: en
Pages: 101
Authors: National Academies of Sciences, Engineering, and Medicine
Categories: Science
Type: BOOK - Published: 2016-10-25 - Publisher: National Academies Press

DOWNLOAD EBOOK

The U.S. Global Change Research Program (USGCRP) was established in 1990 to "assist the Nation and the world to understand, assess, predict, and respond to huma
Characterizing Risk in Climate Change Assessments
Language: en
Pages: 101
Authors: National Academies of Sciences, Engineering, and Medicine
Categories: Science
Type: BOOK - Published: 2016-11-25 - Publisher: National Academies Press

DOWNLOAD EBOOK

The U.S. Global Change Research Program (USGCRP) was established in 1990 to "assist the Nation and the world to understand, assess, predict, and respond to huma
Climate Extremes and Their Implications for Impact and Risk Assessment
Language: en
Pages: 378
Authors: Jana Sillmann
Categories: Science
Type: BOOK - Published: 2019-11-20 - Publisher: Elsevier

DOWNLOAD EBOOK

Climate extremes often imply significant impacts on human and natural systems, and these extreme events are anticipated to be among the potentially most harmful
Climate Change and Development
Language: en
Pages: 395
Authors: Thomas Tanner
Categories: Science
Type: BOOK - Published: 2014-01-10 - Publisher: Routledge

DOWNLOAD EBOOK

The evidence for human-induced climate change is now overwhelming, the brunt of its impacts is already being felt by poor people, and the case for urgent action
Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products
Language: en
Pages: 123
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2014-12-19 - Publisher: National Academies Press

DOWNLOAD EBOOK

Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying